LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Lexaria Bioscience Corp.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026
$2.60−0.26 (-9.09%)
Close on Oct 19, 2026
- Market cap
- $64.50M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Lexaria Bioscience's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 7, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2026 | Sep 1, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 17, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2026 | Jul 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Nov 30, 2025 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 14, 2025 | Dec 16, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 27, 2026 | Dec 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Aug 31, 2025 | Nov 28, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 19, 2025 | Sep 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2025 | Jul 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Nov 30, 2024 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2024 | Jan 3, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 18, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 14, 2025 | Nov 27, 2024 | SEC EDGAR |
| Annual report | 10-K | Aug 31, 2024 | Nov 26, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2024 | Oct 18, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2024 | Oct 16, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 2, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2024 | Sep 5, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2024 | Aug 22, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2024 | Jul 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2024 | Jul 12, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2024 | Apr 30, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2024 | Apr 24, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 29, 2024 | Apr 9, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 15, 2024 | Mar 21, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2024 | Mar 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 27, 2024 | Mar 6, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 29, 2024 | Mar 1, 2024 | SEC EDGAR |